Data presented show sensitivities of 88% for colorectal cancer and 31% for advanced precancerous lesions at 90% specificity
Scientific insights reflect Exact Sciences’ commitment to closing the screening gap through innovation
Results shared alongside evidence supporting multi-cancer early detection approach
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.